NYSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/22/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization51,345 mln
Float1,578 mln
Earnings Date07/30/2026
EPS
0.38
Overpriced
P / E
42.76
High premium
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.73
Likely reliable
1-Year Forecast
20.44
Strong upside
Relative Strength
33
/ 100
Underperforming
Business Description
Founded in 1781 and based in Tokyo, Takeda is one of the world's leading pharmaceutical companies, developing and selling medicines across a range of treatment areas including digestive health, cancer, rare diseases, and mental health. The company markets dozens of established drug brands globally and works alongside a broad network of research and industry partners to discover and bring new treatments to patients.
